The world's only omics-based pharmaceutical company
Develop innovative medicines for immunity-related inflammation and treating rare diseases
Discover omics-based biomarkers and efficacy
Research molecularly targeted mechanisms to control diseases
Research technology to diagnose early stages of cancer